Data / Form D filings / Kiyatec Inc.
Kiyatec Inc.: Form D filings
Kiyatec Inc., a biotechnology company in Greenville, SC, filed 10 Form D notices with the SEC between 2012 and 2024. The latest, on November 6, 2024, reports $250,000 sold of a $5.4 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 N MAIN STREET, Greenville, SC, 29601
- Phone
- (864) 412-4151
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1,000,001 - $5,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1547577
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Amendment | $5,412,500 | $250,000 | $5,162,500 | 1 | Oct 22, 2024 | sec.gov |
| Nov 6, 2024 | New notice | $5,412,500 | $250,000 | $5,162,500 | 1 | Oct 22, 2024 | sec.gov |
| Dec 9, 2022 | New notice | $24,613,620 | $18,057,766 | $6,555,854 | 23 | Nov 23, 2022 | sec.gov |
| Mar 11, 2019 | New notice | $14,330,808 | $5,330,777 | $9,000,031 | 15 | Feb 22, 2019 | sec.gov |
| Nov 27, 2017 | New notice | $2,000,000 | $0 | $2,000,000 | 0 | Yet to occur | sec.gov |
| Oct 28, 2016 | Amendment | $5,248,125 | $3,148,408 | $2,099,717 | 24 | Nov 9, 2015 | sec.gov |
| Nov 6, 2015 | New notice | $3,148,875 | $0 | $3,148,875 | 0 | Yet to occur | sec.gov |
| Dec 8, 2014 | New notice | $500,000 | $180,000 | $320,000 | 3 | Nov 6, 2014 | sec.gov |
| Apr 28, 2014 | New notice | $500,500 | $0 | $500,500 | 0 | Yet to occur | sec.gov |
| Apr 17, 2012 | New notice | $2,822,570 | $0 | $2,822,570 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Eric Perreault | Executive Officer, Director | |
| Christopher Brotherton | Director | |
| Matthew Gevaert | Director | |
| Melissa Rayner | Executive Officer | |
| Scott Isacksen | Executive Officer | |
| Jason Robart | Director | |
| Robert Silverman | Director | |
| Bruce Nash | Director |
Every Form D from the week of Nov 4, 2024 · All recent filings in South Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kiyatec Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.